A new approach to prevent type 2 diabetes may be on the horizon. The use of exendin-4 in newborns may prevent diabetes later in life.…

Hemoglobin A1c is not a reliable marker of dysglycemia in overweight or obese children and adolescents.…

Low levels of the sex hormone might raise men’s risk of dying from heart disease.…

An FDA advisory committee has recommended unanimously that the ezetimibe-simvastatin combination pill (Vytorin) be approved for prevention of cardiovascular disease in CKD patients who are not on dialysis.…

Individuals with diabetes have increased mortality rates compared with the general population. In patients with type 2 diabetes, depression further contributes to the increased mortality.…

Tighter control in children and adolescents with type 1 diabetes lowers the prevalence of retinopathy….

A new study has found that omega-3 fatty acids, better known as fish oil, may help to protect against chronic inflammation and insulin resistance.…

We all are familiar with the effects of GLP-1 analogs and DPP-4 inhibitors, and we make choices for our patients based on the different benefits and risks of each type of drug. This week’s set of Homerun Slides, Incretins, Part 5 of 6, brings to light why there are actions …

Edited by Frank J. Snoek and T. Chas Skinner Introduction to Diabetes in Children    The results of the Diabetes Control and Complications Trial1,2 focused the attention of the medical community on the importance of maintaining blood glucose levels as close to the normal range as possible in order to …

In this week’s Homerun Slides, Incretins, Part 5 of 6, we review the tissue-specific differences in the mechanisms of action of GLP-1 analogs, DPP-4 inhibitors, and GLP-1R agonists and also discuss the weight effects of sitagliptin and pioglitazone….